INSP
Inspire Medical Systems, Inc.
NYSE · Healthcare · Medical - Devices · US
$70.15
+1.98%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$69.27
From 52W high−51.28%
Volume620207.00
Market cap$2.03B
P/E (TTM)15.1x
P/S (TTM)2.3x
Div yield—
Key dataOct 19, 2026
Open
$69.27
From 52W high
−51.28%
Volume
620207.00
Market cap
$2.03B
ValuationView details →
P/E (Fwd)
48.5x
EV/EBITDA
20.9x
P/E (TTM)
15.1x
RSI (14)
52.5
MomentumView details →
1D Return
+1.98%
YTD Return
−24.34%
SummaryUpdated Jun 1, 2026
Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company founded in 2007 and headquartered in Golden Valley, Minnesota. The company went public in May 2018 and has established itself as a pioneer in neurostimulation therapy for obstructive sleep apnea (OSA). Since its founding, Inspire has grown from a development-stage company to a profitable enterprise that has treated over 100,000 patients worldwide. The company achieved its first full year of profitability in 2024, marking a significant milestone in its commercial journey.
Similar companies
Latest newsMore news →
Inspire Medical Systems announced it will release its third quarter 2026 financial results on November 2, 2026, followed by a conference call.14d agoBank of America Corp DE reduced its stake in Inspire Medical Systems, Inc. by 11.4% during the quarter, selling 24,057 shares, according to its 13F filing.56d ago